Andreas Halvorsen Viking Global Investors
Andreas Halvorsen is the founder of Viking Global Investors, another prominent firm with roots in Julian Robertson’s Tiger Management. Viking is known for fundamental long/short equity investing and a large, research-intensive platform. Its public filings are widely monitored for institutional-quality growth and cyclical equity ideas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
lululemon athletica
LULU
|
+$594M |
| 2 |
Sherwin-Williams
SHW
|
+$515M |
| 3 |
UnitedHealth
UNH
|
+$402M |
| 4 |
McKesson
MCK
|
+$362M |
| 5 |
Fortinet
FTNT
|
+$270M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$608M |
| 2 |
Amazon
AMZN
|
+$469M |
| 3 |
Boston Scientific
BSX
|
+$395M |
| 4 |
Mastercard
MA
|
+$331M |
| 5 |
Micron Technology
MU
|
+$322M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.59% |
| 2 | Financials | 17.87% |
| 3 | Technology | 16.44% |
| 4 | Industrials | 12.34% |
| 5 | Consumer Discretionary | 9.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTLT
51
DELISTED
CATALENT, INC.
CTLT
| $78.9M | 0.37% |
1,201,210
-223,178
| -16% | -$13.8M |
|
52
Alkermes
ALKS
$8.11B
| $78.4M | 0.37% |
+2,781,917
| New | +$75.8M |
|
53
Zai Lab
ZLAB
$2.92B
| $77.5M | 0.36% |
2,331,245
+357,648
| +18% | +$13.7M |
|
54
International Flavors & Fragrances
IFF
$21.5B
| $74.7M | 0.35% |
812,680
+373,320
| +85% | +$37.1M |
|
55
4D Molecular Therapeutics
FDMT
$875M
| $67.7M | 0.32% |
3,937,914
| – | – |
|
56
Travelers Companies
TRV
$75.8B
| $64.9M | 0.3% |
+378,345
| New | +$68.8M |
|
57
Guardant Health
GH
$22.9B
| $59.5M | 0.28% |
2,538,889
-1,568,755
| -38% | -$44.8M |
|
58
Snowflake
SNOW
$115B
| $59.1M | 0.28% |
+382,757
| New | +$56.1M |
|
59
Intellia Therapeutics
NTLA
$1.8B
| $58.5M | 0.27% |
1,569,545
-451,865
| -22% | -$17.7M |
|
|
60
Boston Scientific
BSX
$73B
| $56.9M | 0.27% |
1,136,881
-8,391,712
| -88% | -$395M |
|
61
NewAmsterdam Pharma
NAMS
$3.33B
| $52.6M | 0.25% |
3,915,870
+162,042
| +4% | +$2.04M |
|
62
Colgate-Palmolive
CL
$72.6B
| $49.7M | 0.23% |
+660,698
| New | +$49.1M |
|
63
Dell
DELL
$286B
| $44M | 0.21% |
+1,094,394
| New | +$44.1M |
|
|
CNH
64
CNH Industrial
CNH
$19.1B
| $43.2M | 0.2% |
+2,827,515
| New | +$45.8M |
|
|
MRSH
65
Marsh
MRSH
$91.6B
| $42.9M | 0.2% |
+257,443
| New | +$42.9M |
|
|
FTCH
66
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $34.9M | 0.16% |
7,103,457
+332,222
| +5% | +$1.8M |
|
67
Option Care Health
OPCH
$3.55B
| $34.6M | 0.16% |
+1,090,497
| New | +$32.7M |
|
68
Edgewise Therapeutics
EWTX
$4.8B
| $32.7M | 0.15% |
4,909,146
+500,000
| +11% | +$4.63M |
|
69
Viking Therapeutics
VKTX
$3.95B
| $32.6M | 0.15% |
+1,955,063
| New | +$20.2M |
|
70
TJX Companies
TJX
$155B
| $32.5M | 0.15% |
+414,401
| New | +$32.6M |
|
71
Pharvaris
PHVS
$2.55B
| $25.3M | 0.12% |
3,231,923
| – | – |
|
72
Rallybio
RLYB
$89.4M
| $24M | 0.11% |
524,347
| – | – |
|
|
DAWN
73
DELISTED
Day One Biopharmaceuticals
DAWN
| $20.8M | 0.1% |
1,558,563
| – | – |
|
74
PepGen
PEPG
$217M
| $18.9M | 0.09% |
1,544,631
| – | – |
|
|
KNTE
75
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $11.4M | 0.05% |
1,820,462
| – | – |
|
Similar funds
Andreas Halvorsen's Q1 2023 Portfolio in Review
As of Q1 2023, Andreas Halvorsen held 96 positions worth $21.3B, up 6.7% from $20B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Andreas Halvorsen's Q1 2023 filing shows 20 new, 27 increased, 19 reduced and 15 closed positions. Its largest new stake was lululemon athletica: 1,893,883 shares worth $690M. The largest sale was Microsoft, an estimated $608M.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 38% a quarter earlier, followed by Financials and Technology.
- Andreas Halvorsen's largest Q1 2023 buy was lululemon athletica: 1,893,883 shares worth $690M.
- Andreas Halvorsen added most to UnitedHealth in Q1 2023, an estimated $402M increase.
- Andreas Halvorsen's biggest Q1 2023 reduction was Microsoft, cutting an estimated $608M.
- Andreas Halvorsen fully exited Brookfield in Q1 2023, selling an estimated $228M.
- Andreas Halvorsen's ten largest holdings make up 43% of its $21.3B portfolio in Q1 2023.
- Andreas Halvorsen opened 20 new positions and closed 15 in Q1 2023.
- Andreas Halvorsen's portfolio value rose 6.7% quarter-over-quarter to $21.3B.
Based on Viking Global Investors's 13F filing for Q1 2023, filed 15 May 2023.